- Report
- October 2026
- 177 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 340 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 382 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 388 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 282 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 367 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 372 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 375 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 380 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 473 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 439 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 348 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 377 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 276 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 372 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 242 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 306 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 393 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 288 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 382 Pages
Global
From €5388EUR$5,850USD£4,554GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more